Glycosylation Enhances the Physicochemical Properties of Caffeic Acid Phenethyl Ester
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
In this study, we synthesized a glycosylated derivative of caffeic acid phenethyl ester (CAPE) using the amylosucrase from Deinococcus geothermalis with sucrose as a substrate and examined its solubility, chemical stability, and anti-inflammatory activity. Nuclear magnetic resonance spectroscopy showed that the resulting glycosylated CAPE (G-CAPE) was the new compound caffeic acid phenethyl ester-4-O-α-D-glucopyranoside. G-CAPE was 770 times more soluble than CAPE and highly stable in Dulbecco’s modified Eagle’s medium and buffered solutions, as estimated by its half-life. The glycosylation of CAPE did not significantly affect its anti-inflammatory activity, which was assessed by examining lipopolysaccharide-induced nitric oxide production and using a nuclear factor erythroid 2-related factor 2 reporter assay. Furthermore, a cellular uptake experiment using high-performance liquid chromatography analysis of the cell-free extracts of RAW 264.7 cells demonstrated that G-CAPE was gradually converted to CAPE within the cells. These results demonstrate that the glycosylation of CAPE increases its bioavailability by helping to protect this vital molecule from chemical or enzymatic oxidation, indicating that G-CAPE is a promising candidate for prodrug therapy.
Abstract
In this study, we synthesized a glycosylated derivative of caffeic acid phenethyl ester (CAPE) using the amylosucrase from Deinococcus geothermalis with sucrose as a substrate and examined its solubility, chemical stability, and anti-inflammatory activity. Nuclear magnetic resonance spectroscopy showed that the resulting glycosylated CAPE (G-CAPE) was the new compound caffeic acid phenethyl ester-4-O-α-D-glucopyranoside. G-CAPE was 770 times more soluble than CAPE and highly stable in Dulbecco’s modified Eagle’s medium and buffered solutions, as estimated by its half-life. The glycosylation of CAPE did not significantly affect its anti-inflammatory activity, which was assessed by examining lipopolysaccharide-induced nitric oxide production and using a nuclear factor erythroid 2-related factor 2 reporter assay. Furthermore, a cellular uptake experiment using high-performance liquid chromatography analysis of the cell-free extracts of RAW 264.7 cells demonstrated that G-CAPE was gradually converted to CAPE within the cells. These results demonstrate that the glycosylation of CAPE increases its bioavailability by helping to protect this vital molecule from chemical or enzymatic oxidation, indicating that G-CAPE is a promising candidate for prodrug therapy.
참고문헌 (43)
- Viuda-Martos M, "Functional properties of honey, propolis, and royal jelly", J. Food Sci, 73, pp.R117~R124 (2008)
- Chiao C, "Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells", Cancer Res, 55, pp.3576~3583 (1995)
- Natarajan K, "Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B", Proc. Natl. Acad. Sci. USA, 93, pp.9090~9095 (1996)
- Song YS, "Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity", Cancer Lett, 175, pp.53~61 (2002)
- Toyoda T, "Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils", Int. J. Cancer, 125, pp.1786~1795 (2009)
- Orsolic N, "Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth", Biol. Pharm. Bull, 28, pp.1928~1933 (2005)
- Tolba MF, "Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities:a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects", IUBMB Life, 65, pp.699~709 (2013)
- Armutcu F, "Therapeutic potential of caffeic acid phenethyl ester and its antiinflammatory and immunomodulatory effects (Review)", Exp. Ther. Med, 9, pp.1582~1588 (2015)
- Erdemli HK, "Antiviral properties of caffeic acid phenethyl ester and its potential application", J. Intercult. Ethnopharmacol, 4, pp.344~347 (2015)
- Juman S, "Caffeic acid phenethyl ester suppresses the production of pro-inflammatory cytokines in hypertrophic adipocytes through lipopolysaccharide-stimulated macrophages", Biol. Pharm. Bull, 35, pp.1941~1946 (2012)
- Song JJ, "Effect of caffeic acid phenethyl ester (CAPE) on H2O2 induced oxidative and inflammatory responses in human middle ear epithelial cells", Int. J. Pediatr. Otorhinolaryngol, 76, pp.675~679 (2012)
- Akyol S, "The potential usage of caffeic acid phenethyl ester (CAPE) against chemotherapy-induced and radiotherapyinduced toxicity", Cell Biochem. Funct, 30, pp.438~443 (2012)
- Craig DQ., "The mechanisms of drug release from solid dispersions in water-soluble polymers", Int. J. Pharm, 231, pp.131~144 (2002)
- Leuner C, "Improving drug solubility for oral delivery using solid dispersions", Eur. J. Pharm. Biopharm, 50, pp.47~60 (2000)
- Couvreur P, "Nanotechnologies for designing new medicines", Biol. Aujourdhui, 206, pp.237~248 (2012)
- Dinarvand R, "Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents", Int. J. Nanomedicine, 6, pp.877~895 (2011)
- Steichen SD, "A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics", Eur. J. Pharm. Sci, 48, pp.416~427 (2013)
- Kim MK, "Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM)promoiety", J. Med. Chem, 53, pp.8597~8607 (2010)
- Szente L, "Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development", Adv. Drug Deliv. Rev, 36, pp.17~28 (1999)
- Park H, "Enzymatic synthesis of piceid glucosides using maltosyltransferase from Caldicellulosiruptor bescii DSM 6725", J. Agric. Food Chem, 60, pp.8183~8189 (2012)
- Kometani T, "Transglycosylation to hesperidin by cyclodextrin glucanotransferase from an alkalophilic Bacillus species in alkaline pH and properties of hesperidin glycosides", Biosci. Biotechnol. Biochem, 58, pp.1990~1994 (1994)
- Yamada M, "Bioavailability of glucosyl hesperidin in rats", Biosci. Biotechnol. Biochem, 70, pp.1386~1394 (2006)
- Ohtsuki K, "Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature", J. Nutr. Sci. Vitaminol. (Tokyo), 49, pp.447~450 (2003)
- Seo DH, "Highly selective biotransformation of arbutin to arbutin-alpha-glucoside using amylosucrase from Deinococcus geothermalis DSM 11300", J. Mol. Catal. B Enzym, 60, pp.113~118 (2009)
- Jung JH, "Enzymatic synthesis of salicin glycosides through transglycosylation catalyzed by amylosucrases from Deinococcus geothermalis and Neisseria polysaccharea", Carbohydr. Res, 344, pp.1612~1619 (2009)
- Cho HK, "Biosynthesis of (+)-catechin glycosides using recombinant amylosucrase from Deinococcus geothermalis DSM 11300", Enzyme Microb. Technol, 49, pp.246~253 (2011)
- Kim KH, "Synthesis and biological evaluation of a novel baicalein glycoside as an anti-inflammatory agent", Eur. J. Pharmacol, 744, pp.147~156 (2014)
- 김묘덕, "Acceptor Specificity of Amylosucrase from Deinococcus radiopugnans and Its Application for Synthesis of Rutin Derivatives", Journal of Microbiology and Biotechnology, 26(11), pp.1845~1854 (2016), 한국미생물·생명공학회
- Choi JY, "Protective effect of the fruit hull of Gleditsia sinensis on LPS-induced acute lung injury is associated with Nrf2 activation", Evid. Based Complement. Alternat. Med, 2012, pp.974713~ (2012)
- Kim KH, "Glycosylation enables aesculin to activate Nrf2", Sci. Rep, 6, pp.29956~ (2016)
- Emond S, "Cloning, purification and characterization of a thermostable amylosucrase from Deinococcus geothermalis", FEMS Microbiol. Lett, 285, pp.25~32 (2008)
- Nishimura T, "Glucosylation of caffeic acid with Bacillus subtilis X-23alpha-amylase and a description of the glucosides", J. Ferment. Bioeng, 80, pp.18~23 (1995)
- Meng W, "Stability of active ingredients of traditional Chinese medicine (TCM)", Nat. Prod. Commun, 4, pp.1761~1776 (2009)
- Walle T, "Improving m etab olic stability of cancer chemoprotective polyphenols", Expert Opin. Drug Metab. Toxicol, 3, pp.379~388 (2007)
- Jung WK, "Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38", ERK and NF-kappa B pathways, 2008, pp.40, 2572~2582
- Kim H, "Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation", Free Radic. Biol. Med, 65, pp.552~562 (2013)
- Stella VJ, "Prodrug strategies to overcome poor water solubility", Adv. Drug Deliv. Rev, 59, pp.677~694 (2007)
- Rautio J, "Prodrugs: design and clinical applications", Nat. Rev. Drug Discov, 7, pp.255~270 (2008)
- Celli N, "In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis", J. Agric. Food Chem, 55, pp.3398~3407 (2007)
- Woo HJ, "Synthesis and characterization of ampelopsin glucosides using dextransucrase from Leuconostoc mesenteroides B-1299CB4: glucosylation enhancing physicochemical properties", Enzyme Microb. Technol, 51, pp.311~318 (2012)
- Moon YH, "Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB", J. Agric. Food Chem, 54, pp.1230~1237 (2006)
- Lee SJ, "Transglycosylation of naringin by Bacillus stearothermophilus maltogenic amylase to give glycosylated naringin", J. Agric. Food Chem, 47, pp.3669~3674 (1999)
- 고진아, "Enzymatic Synthesis of Puerarin Glucosides Using Leuconostoc Dextransucrase", Journal of Microbiology and Biotechnology, 22(9), pp.1224~1229 (2012), 한국미생물·생명공학회[DOI]